跳至主要内容
临床试验/CTRI/2024/05/067893
CTRI/2024/05/067893尚未招募2 期

A COMPARATIVE STUDY OF EFFICACY OF BALA TAILA NASYA AND M-7 (HYPOTHETICAL DRUG) IN THE MANAGEMENT OF ARDHAVABHEDAKA W.S.R. TO MIGRAIN - NI

PGIASR RAU JODHPUR RAJASTHA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients’ between 16 to 60 years of age.
  • 2.Patients with clinical signs and symptoms of Ardhavbhedaka.
  • 3.Patients of either sex irrespective of their occupation, religion and socio-economic status.
  • 4.Patients fit for Bala ail Nasya and Migro-7
  • Powder (hypothetical drug).
  • 5. Patients willing to participate in trial and
  • follow up with a signed consent.

排除标准

  • 1.Secondary headaches caused by meningitis, tumors, encephalitis, head and neck trauma, trigeminal neuralgia, cervical spondylitis, refractive errors, sinusitis and other disorders of cranium, neck, eyes, ears, nose, sinuses, teeth etc.
  • 2.Patients with complicated Migraine like status migrainosus, hemiplegic migraine and having any chronic debilitating disease with other neurological pathology.
  • 3.Pregnant and lactating women.
  • 4.Patients suffering from any other major systemic disorders e.g. tuberculosis, cancer, heart disease etc.

研究者

发起方
PGIASR RAU JODHPUR RAJASTHA

相似试验